CPSA Europe 2020

Meeting Programme

Updated 13 November, 2019

Tuesday | Wednesday | Thursday | Friday

Tuesday February 4

12:00 pm

Lobby

Registration

Front Lobby

1:00 pm - 4:30 pm

Pre-Conference Workshops

Queen's Room

WORKSHOP 1
To Be Announced

Magdalene Room

WORKSHOP 2
To Be Announced

6:00 PM - 9:00 pm

College Suite

Welcome Reception & IMAGINE SUMMIT

Imagine Summit
Building Tomorrow Today

Welcome
Neil Spooner, Spooner Bioanalytical Solutions and
Emily Ehrenfeld, New Objective

Melanie Anderson

Imagineer
Christophe Stove
University of Ghent

Wednesday February 5

7:00 AM - 8:30 AM

Lobby

Registration

Front Lobby

8:30 AM - 8:45 AM

University Suite

Welcome & Opening Remarks

Mike Lee

Welcome
Mike Lee
Milestone Development Services

Neil Spooner

Format, Objectives, Opening Remarks
Neil Spooner
Spooner Bioanalytical Solutions

Ismael Zamora


Ismael Zamora
Molecular Discovery

8:45 am - 9:30 am

University Suite

Plenary Lecture

Duchenne Muscular Dystrophy – Why the Way We Sample Blood Matters
"Mum - why don’t they just punch me in the face?"

Plenary Speaker

Fleur Chandler

Duchenne UK

9:45 am - 11:30 am

University Suite

Session 1
Symposium Session

Pushing the Boundaries of Sample Collection – Near and Small

Discussion Leaders: Emily Ehrenfeld, New Objective; Matt Barfield, GlaxoSmithKline

11:30 am - 1:00 pm

Parallel Sessions

University Suite

Session 2
To Be Announced

Discussion Leaders: Britta Bonn, AstraZeneca; Axel Paehler, Roche

Corpus Christi Room

Session 3
Getting the ‘i’ into Clinical Trials
(To Improve Patient Outcomes and Data Integrity)

Discussion Leaders: Jenny Royle, DigitalECMT; Scott Summerfield, GlaxoSmithKline

1:15 pm - 2:45 pm

College Suite

Sponsored Lunch & Roundtable

2:45 pm - 4:15 pm

University Suite

Workshop

To Be Announced

Discussion Leaders: Britta Bonn, AstraZeneca; Ute Gerhard, University of Hertfordshire; Emre Isin, UCB; Darragh Murnane, University of Hertfordshire

4:30 pm - 6:00 pm

Parallel Sessions

University Room

SESSION 4
To Be Announced

Discussion Leaders: Amanda Wilson, AstraZeneca; Jason Wrigley, Merck (MilliporeSigma in USA/Canada)

Corpus Christi Room

SESSION 5
To Be Announced

Discussion Leaders: David Browne, PRA Health Sciences;  Michelle Reid, ETH Zurich

To Be Announced
Michael Morris, Waters Corporation

To Be Announced
Tim Heinermann, ETH Zurich

6:00 pm

University Suite

CPSA EUROPE GROUP PHOTO

Please gather toegther to capture the 3rd Annual CPSA Europe gathering with a group photo—including organizers, speakers, attendees—everyone!

6:30 pm - 8:30 pm

College Suite

Sponsored Reception & Dinner

Thursday February 6

7:00 AM - 8:30 AM

Lobby

Registration

Front Lobby

8:30 am - 10:00 am

University Suite

Session 1
Symposium Session

To Be Announced

Discussion Leaders: Pawan Singh, Trajan Medical & Scientific; and Emre Isin, UCB

10:15 am - 11:45 am

The University Suite

Session 2
Symposium Session

To Be Announced

Discussion Leaders: Elizabeth Thomas, Alderley Analytical; Nathan Hawkins, Anatune; Jason Wrigley, Merck (MilliporeSigma in USA/Canada); Neil Spooner, Spooner Bioanalytical Solutions

12:00 pm - 1:30 pm

College Suite

Sponsored Lunch & Roundtable

1:30 pm - 3:00 pm

University Suite

WORKSHOP 1
WORKSHOP

Are Current Clinical Chemistry Tests Still Fit for Purpose?

Discussion Leaders: Amanda Wilson, AstraZeneca;
James Rudge, Neoteryx

To Be Announced
Brian Keevil, Manchester University NHS Foundation Trust

3:15 pm - 4:45 pm

Parallel Sessions

University Suite

SESSION 3
The Bedside Bioanalyst

Discussion Leaders: Ian Wilson, Imperial College (London); John Smeraglia, UCB

Bringing high quality analytical chemistry to the patient in the operating theatre, at their bedside, in the GP's surgery, or their own homes for therapeutic drug monitoring, biomarker analysis, diagnosis and therapy monitoring.

If we have learned nothing from the Theranos scandal its that there is both a need, and an appetite, from individuals for good, accurate and reliable analytical information about health, disease the causes and time-course of disease, and the outcome of therapies.

How can we deliver it?

Corpus Christi Room

SESSION 4
Social Media and Scientific Publishing in the 21st Century

Discussion Leaders: Laura Dormer, Future Science Group; Shane Needham, Alturas Analytics

Discussion Panel:
Jenny Royle, DigitalECMT
Michell Reid, ETH Zurich
Jason Wrigley, Merck (MilliporeSigma in USA/Canada)

5:00 pm - 6:30 pm

The University Suite

Vendor Session

"Five Minutes of Fame"

Discussion Leaders: Elizabeth Thomas, Alderley Analytical; Neil Spooner, Spooner Bioanalytical Solutions; Mike Lee, Milestone Development Services

Participants are given the opportunity to present their idea, company, products and services to the participants of CPSA Europe 2020 using any format they'd like. The only rule is it is limited to just 5 minutes! Be bold, have fun, get noticed and make a statement.

6:30 pm - 8:30 pm

College Suite

Sponsored Evening Event & Dinner

Friday February 7

7:00 AM - 8:30 AM

Lobby

Registration

Front Lobby

8:30 am - 10:15 am

Peterhouse Room

Session 1
Symposium Session

The Future of Digital Biomarkers

Discussion Leaders: Kevin Bateman, MSD (Merck & Co. in USA/Canada; James Rudge, Neoteryx; Jenny Royle, DigitalECMT

The Potential of Digital Biomarkers to Transform Drug Development
Marissa Dockendorf, MSD (Merck & Co. in USA/Canada)

Can Remote Blood Testing and Digital Biomarkers Drive Behavioural Change?
Bala Sirigireddy, NHS Clinical Entrepreneur Fellow

Digital Biomarkers – What’s the Point?
Early Clinical Trial Experience
Jenny Royle, DigitalECMT

10:15 am - 12:00 pm

Peterhouse Room

Session 2
Symposium Session

Little by Little: How Low Should We Go with Sample Size and Detection Limits?

Discussion Leaders: Christophe Stove, Ghent University; Ute Gerhard, University of Hertfordshire; Darragh Murnane, University of Hertfordshire

12:00 pm - 1:30 pm

Peterhouse Room

Lunch & Symposium Session

How Does Software Impact Your Scientific Life? It’s Getting Personal!

Discussion Leaders: Ismael Zamora, Molecular Discovery

The capabilities of scientific software, such as those used for metabolite identification, are becoming increasingly sophisticated. This is now coming to the point where these solutions are able to fulfil many of the functions currently performed by skilled scientists, which brings us to an interesting junction….. This discussion based sessions will encourage attendees to reflect on where we might be goings with regards to these solutions. What might be the benefits and risks of their implementation and how should we be moving forwards to enable us to develop better solutions for human wellbeing and the patients that are waiting for better diagnoses and medicines.

1:30 pm

Peterhouse Room

Closing Remarks

Neil Spooner, Spooner Bioanalytical Solutions
Ismael Zamora, Molecular Discovery
Mike Lee, Milestone Development Services